Kunyan Li
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 22, 2025
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 24, 2023
Procedures for application of the extended dosing after antitumor drug clinical trials.
Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Published: June 29, 2023
Benefit assessment of extended dosing in cancer patients after their withdrawal from clinical trials.
Journal: Frontiers in pharmacology
Published: March 02, 2023
Can CT Radiomics Detect Acquired T790M Mutation and Predict Prognosis in Advanced Lung Adenocarcinoma With Progression After First- or Second-Generation EGFR TKIs?
Journal: Frontiers in oncology
Published: March 26, 2022
SHR2554, an EZH2 inhibitor, in relapsed or refractory mature lymphoid neoplasms: a first-in-human, dose-escalation, dose-expansion, and clinical expansion phase 1 trial.
Journal: The Lancet. Haematology
Published: February 24, 2022
Corrigendum to ' Evaluation of the pharmacokinetic effects of itraconazole on alflutinib (AST2818): an open-label, single-center, single-sequence, two-period randomized study in healthy volunteers'[European Journal of Pharmaceutical Sciences 162 (2021) 105815].
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: February 19, 2022
Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: December 11, 2021
Effect of fluconazole on the pharmacokinetics of fuzuloparib: an open-label, crossover study in Chinese healthy male volunteers.
Journal: Cancer chemotherapy and pharmacology
Published: April 08, 2021
A Randomized, Open, Single-Centre, Crossed Study of the Effect of Food on the Pharmacokinetics of One Oral Dose of Alflutinib Mesylate Tablets (AST2818) in Healthy Male Subjects.
Journal: Iranian journal of pharmaceutical research : IJPR
Published: March 08, 2021
Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy.
Journal: Journal of the National Cancer Institute
Published: October 29, 2020
The new Good Clinical Practice-2020 in China: Views from ethical perspective.
Journal: The Lancet regional health. Western Pacific
Published: October 03, 2020
Last Updated: 09/26/2026